Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, SVY, ECO

CB Insights Names Clarius Mobile Health to Its Digital Health 150 List


Clarius recognized for market leading growth and helping to drive better patient outcomes by increasing the use of ultrasound by medical specialists.

NEW YORK, Dec. 7, 2022 /PRNewswire/ -- CB Insights today named Clarius Mobile Health to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022. A leading provider of high-definition wireless ultrasound systems, Clarius helps clinicians from a broad range of specialties improve patient care, expand their services, and differentiate their medical practices with real-time imaging inside the body.

"From reimagining clinical care, to leveraging tech like AR/VR to improve surgical training, this year's Digital Health 150 winners are transforming the future of healthcare with digital technology," said Brian Lee, SVP of CB Insights' Intelligence Unit. "This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year's winners." 

Clarius is one of 150 companies selected from a pool of more than 13,000 private companies. The research team used the CB Insights platform to select the 150 winners based on factors including R&D activity, proprietary Mosaic scores, market potential, business relationships, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty. The research team also reviewed over 3,000 Analyst Briefings submitted by applicants. 

"2022 has been a truly remarkable year for Clarius and we are honoured to be among the elite healthcare companies that CB Insights has chosen for this year's Digital Health 150 List," said Clarius President and CEO Ohad Arazi. "With the introduction of our third-generation handheld ultrasound scanners, we took a big leap forward in our mission to enable medical imaging in every setting. By fusing innovations from the digital health and medical device domains, handheld ultrasound can play a tremendous role in transforming patient outcomes, decreasing healthcare costs, and enhancing collaboration. We look forward to continuing our record sales growth as we enter the new year."

Clarius began the year with the global launch of ten new wireless handheld ultrasound scanners that operate with an easy-to-use app on iOS and Android smart devices that's powered by artificial intelligence (AI). For the first time, Clarius also introduced a software-as-a-service membership offering, which offers cloud storage, advanced software options for seven specialties, and Clarius education delivered by industry experts. More than 90% of new customers took advantage of the new offering, becoming Clarius Members. Most recently, the company introduced Clarius Marketplace, a new open software platform that empowers partners to seamlessly integrate their advanced AI solutions with Clarius wireless ultrasound systems.

Dr. Don Buford, a board-certified orthopedic surgeon specializing in sports medicine and regenerative medicine, recommends the new Clarius HD3 because it delivers superior image quality in an affordable handheld device. "Investing in Clarius is a no-brainer because the payoff for Clarius is fast. And the image quality is fantastic. The linear scanner is on par with compact systems, no question."

About CB Insights 

CB Insights builds software that enables the world's best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. To learn more, please visit www.cbinsights.com

Contact:
Chris Orlando
[email protected]  

About Clarius Mobile Health 

Clarius is on a mission to make accurate, easy-to-use, and affordable ultrasound tools available to all medical professionals in every specialty. With decades of experience in medical imaging, the team knows that great ultrasound imaging improves confidence and patient care. Today, Clarius handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost. 

Over two million high-definition scans have been performed using Clarius wireless handheld scanners. Clarius scanners are available in over 90 countries worldwide. Learn more at www.clarius.com

Clarius Media Contact: 
Genèse Castonguay 
Marketing Vice President 
Phone: +1 (866) 657-9243 ext. 221 | Direct: +1 (604) 260-7077 

SOURCE Clarius Mobile Health


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: